Correlation Between Nova Eye and EROAD

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nova Eye and EROAD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nova Eye and EROAD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nova Eye Medical and EROAD, you can compare the effects of market volatilities on Nova Eye and EROAD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nova Eye with a short position of EROAD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nova Eye and EROAD.

Diversification Opportunities for Nova Eye and EROAD

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nova and EROAD is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Nova Eye Medical and EROAD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EROAD and Nova Eye is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nova Eye Medical are associated (or correlated) with EROAD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EROAD has no effect on the direction of Nova Eye i.e., Nova Eye and EROAD go up and down completely randomly.

Pair Corralation between Nova Eye and EROAD

Assuming the 90 days trading horizon Nova Eye is expected to generate 4.47 times less return on investment than EROAD. In addition to that, Nova Eye is 1.61 times more volatile than EROAD. It trades about 0.01 of its total potential returns per unit of risk. EROAD is currently generating about 0.04 per unit of volatility. If you would invest  63.00  in EROAD on August 25, 2024 and sell it today you would earn a total of  21.00  from holding EROAD or generate 33.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nova Eye Medical  vs.  EROAD

 Performance 
       Timeline  
Nova Eye Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nova Eye Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
EROAD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EROAD has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Nova Eye and EROAD Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nova Eye and EROAD

The main advantage of trading using opposite Nova Eye and EROAD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nova Eye position performs unexpectedly, EROAD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EROAD will offset losses from the drop in EROAD's long position.
The idea behind Nova Eye Medical and EROAD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings